|
WO2012019630A1
(en)
|
2010-08-13 |
2012-02-16 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
|
|
WO2013120499A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly (a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
|
|
RU2658490C2
(ru)
|
2012-03-27 |
2018-06-21 |
Кьюрвак Аг |
Искусственные молекулы нуклеиновых кислот для улучшенной экспрессии белков или пептидов
|
|
RU2718988C2
(ru)
|
2013-02-22 |
2020-04-15 |
Куревак Аг |
Комбинация противораковой рнк-вакцины и ингибитора пути pd-1 и ее применение
|
|
BR112016001192A2
(pt)
|
2013-08-21 |
2017-08-29 |
Curevac Ag |
Vacina contra a raiva
|
|
AU2014310935B2
(en)
|
2013-08-21 |
2019-11-21 |
CureVac SE |
Combination vaccine
|
|
BR112016003361A2
(pt)
|
2013-08-21 |
2017-11-21 |
Curevac Ag |
vacina do vírus sincicial respiratório (rsv)
|
|
ES2806575T3
(es)
|
2013-11-01 |
2021-02-18 |
Curevac Ag |
ARN modificado con propiedades inmunoestimuladoras disminuidas
|
|
WO2015135558A1
(en)
|
2014-03-12 |
2015-09-17 |
Curevac Gmbh |
Combination of vaccination and ox40 agonists
|
|
SG10201912038TA
(en)
|
2014-04-23 |
2020-02-27 |
Modernatx Inc |
Nucleic acid vaccines
|
|
SMT202200502T1
(it)
|
2014-06-25 |
2023-01-13 |
Acuitas Therapeutics Inc |
Nuovi lipidi e formulazioni di nanoparticelle lipidiche per l'erogazione di acidi nucleici
|
|
DE202015010000U1
(de)
|
2014-12-12 |
2023-07-03 |
CureVac SE |
Artifizielle Nukleinsäuremoleküle für eine verbesserte Proteinexpression
|
|
US20180303925A1
(en)
|
2015-04-27 |
2018-10-25 |
The Trustees Of The University Of Pennsylvania |
Nucleoside-Modified RNA For Inducing an Adaptive Immune Response
|
|
DK3294885T3
(da)
|
2015-05-08 |
2020-08-10 |
Curevac Real Estate Gmbh |
Fremgangsmåde til at fremstille rna
|
|
PL4108769T3
(pl)
|
2015-05-29 |
2024-02-05 |
CureVac Manufacturing GmbH |
Sposób wytwarzania i oczyszczania rna obejmujący co najmniej jeden etap filtracji o przepływie stycznym
|
|
LT3313829T
(lt)
|
2015-06-29 |
2024-08-12 |
Acuitas Therapeutics Inc. |
Lipidai ir lipidų nanodalelių sudėtys, skirtos nukleorūgščių tiekimui
|
|
US11364292B2
(en)
|
2015-07-21 |
2022-06-21 |
Modernatx, Inc. |
CHIKV RNA vaccines
|
|
WO2017020026A1
(en)
|
2015-07-30 |
2017-02-02 |
Modernatx, Inc. |
Concatemeric peptide epitopes rnas
|
|
JP6882782B2
(ja)
|
2015-08-04 |
2021-06-02 |
デューク ユニバーシティ |
遺伝子コードされた本質的に無秩序な送達用ステルスポリマーおよびその使用方法
|
|
EP4286012A3
(en)
|
2015-09-17 |
2024-05-29 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
US11225682B2
(en)
|
2015-10-12 |
2022-01-18 |
Curevac Ag |
Automated method for isolation, selection and/or detection of microorganisms or cells comprised in a solution
|
|
EP3364949A4
(en)
|
2015-10-22 |
2019-07-31 |
ModernaTX, Inc. |
CANCER VACCINES
|
|
CA3002912A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Nucleic acid vaccines for varicella zoster virus (vzv)
|
|
EP3364981A4
(en)
|
2015-10-22 |
2019-08-07 |
ModernaTX, Inc. |
VACCINE AGAINST THE HUMAN CYTOMEGALOVIRUS
|
|
TW201729835A
(zh)
|
2015-10-22 |
2017-09-01 |
現代公司 |
呼吸道病毒疫苗
|
|
EP3364950A4
(en)
|
2015-10-22 |
2019-10-23 |
ModernaTX, Inc. |
VACCINES AGAINST TROPICAL DISEASES
|
|
US20180289792A1
(en)
|
2015-10-22 |
2018-10-11 |
ModernaTX. Inc. |
Sexually transmitted disease vaccines
|
|
IL307179A
(en)
|
2015-10-28 |
2023-11-01 |
Acuitas Therapeutics Inc |
Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
US11413346B2
(en)
|
2015-11-09 |
2022-08-16 |
Curevac Ag |
Rotavirus vaccines
|
|
HRP20220652T1
(hr)
|
2015-12-10 |
2022-06-24 |
Modernatx, Inc. |
Pripravci i postupci unosa terapijskih sredstava
|
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
|
HUE057877T2
(hu)
|
2015-12-22 |
2022-06-28 |
Modernatx Inc |
Vegyületek és készítmények terápiás szerek intracelluláris bejuttatására
|
|
EP3701963A1
(en)
|
2015-12-22 |
2020-09-02 |
CureVac AG |
Method for producing rna molecule compositions
|
|
EP3394280A1
(en)
|
2015-12-23 |
2018-10-31 |
CureVac AG |
Method of rna in vitro transcription using a buffer containing a dicarboxylic acid or tricarboxylic acid or a salt thereof
|
|
US11723967B2
(en)
|
2016-02-17 |
2023-08-15 |
CureVac SE |
Zika virus vaccine
|
|
EP3423595A1
(en)
|
2016-03-03 |
2019-01-09 |
CureVac AG |
Rna analysis by total hydrolysis
|
|
EP4631970A3
(en)
|
2016-05-04 |
2026-01-07 |
CureVac SE |
Nucleic acid molecules and uses thereof
|
|
EP3452101A2
(en)
|
2016-05-04 |
2019-03-13 |
CureVac AG |
Rna encoding a therapeutic protein
|
|
WO2017210476A1
(en)
|
2016-06-01 |
2017-12-07 |
Duke University |
Nonfouling biosensors
|
|
WO2017212009A1
(en)
|
2016-06-09 |
2017-12-14 |
Curevac Ag |
Hybrid carriers for nucleic acid cargo
|
|
EP3515928B1
(en)
|
2016-09-23 |
2026-01-28 |
Duke University |
Unstructured non-repetitive polypeptides having lcst behavior
|
|
MA46584A
(fr)
|
2016-10-21 |
2019-08-28 |
Modernatx Inc |
Vaccin contre le cytomégalovirus humain
|
|
BR112019008481A2
(pt)
*
|
2016-10-26 |
2020-03-03 |
Curevac Ag |
Vacinas de mrna de nanopartículas lipídicas
|
|
US12491261B2
(en)
|
2016-10-26 |
2025-12-09 |
Acuitas Therapeutics, Inc. |
Lipid nanoparticle formulations
|
|
WO2018089851A2
(en)
|
2016-11-11 |
2018-05-17 |
Modernatx, Inc. |
Influenza vaccine
|
|
US11279923B2
(en)
|
2016-11-28 |
2022-03-22 |
Curevac Ag |
Method for purifying RNA
|
|
WO2018104540A1
(en)
|
2016-12-08 |
2018-06-14 |
Curevac Ag |
Rnas for wound healing
|
|
EP3551230A1
(en)
|
2016-12-08 |
2019-10-16 |
CureVac AG |
Rna for treatment or prophylaxis of a liver disease
|
|
WO2018115525A1
(en)
|
2016-12-23 |
2018-06-28 |
Curevac Ag |
Lassa virus vaccine
|
|
EP3558356A2
(en)
|
2016-12-23 |
2019-10-30 |
CureVac AG |
Mers coronavirus vaccine
|
|
EP3558355A2
(en)
|
2016-12-23 |
2019-10-30 |
CureVac AG |
Henipavirus vaccine
|
|
WO2018132537A1
(en)
|
2017-01-11 |
2018-07-19 |
The Trustees Of The University Of Pennsylvania |
Nucleoside-modified rna for inducing an immune response against zika virus
|
|
WO2018132732A1
(en)
|
2017-01-12 |
2018-07-19 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
|
US11572389B2
(en)
*
|
2017-01-27 |
2023-02-07 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Vaccine compositions of herpesvirus envelope protein combinations to induce immune response
|
|
EP3595713A4
(en)
|
2017-03-15 |
2021-01-13 |
ModernaTX, Inc. |
RESPIRATORY SYNCYTIAL VIRUS Vaccine
|
|
WO2018170322A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Crystal forms of amino lipids
|
|
US11969506B2
(en)
|
2017-03-15 |
2024-04-30 |
Modernatx, Inc. |
Lipid nanoparticle formulation
|
|
US11752206B2
(en)
*
|
2017-03-15 |
2023-09-12 |
Modernatx, Inc. |
Herpes simplex virus vaccine
|
|
SMT202300097T1
(it)
|
2017-03-15 |
2023-05-12 |
Modernatx Inc |
Composto e composizioni per il rilascio intracellulare di agenti terapeutici
|
|
WO2018170245A1
(en)
*
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Broad spectrum influenza virus vaccine
|
|
US11045540B2
(en)
|
2017-03-15 |
2021-06-29 |
Modernatx, Inc. |
Varicella zoster virus (VZV) vaccine
|
|
MA47790A
(fr)
|
2017-03-17 |
2021-05-05 |
Modernatx Inc |
Vaccins à base d'arn contre des maladies zoonotiques
|
|
AU2018240515B2
(en)
|
2017-03-24 |
2024-07-25 |
CureVac SE |
Nucleic acids encoding CRISPR-associated proteins and uses thereof
|
|
US12303561B2
(en)
*
|
2017-04-03 |
2025-05-20 |
Biontech Us Inc. |
Protein antigens and uses thereof
|
|
WO2018187590A1
(en)
|
2017-04-05 |
2018-10-11 |
Modernatx, Inc. |
Reduction or elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins
|
|
WO2018191657A1
(en)
|
2017-04-13 |
2018-10-18 |
Acuitas Therapeutics, Inc. |
Lipids for delivery of active agents
|
|
JP7464954B2
(ja)
|
2017-04-27 |
2024-04-10 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
Ｃ型肝炎ウイルスに対するヌクレオシド修飾ｍＲＮＡ－脂質ナノ粒子系統ワクチン
|
|
WO2018200943A1
(en)
|
2017-04-28 |
2018-11-01 |
Acuitas Therapeutics, Inc. |
Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
WO2018213320A1
(en)
|
2017-05-15 |
2018-11-22 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
|
WO2018211038A1
(en)
|
2017-05-17 |
2018-11-22 |
Curevac Ag |
Method for determining at least one quality parameter of an rna sample
|
|
WO2018222926A1
(en)
|
2017-05-31 |
2018-12-06 |
Ultragenyx Pharmaceutical Inc. |
Therapeutics for glycogen storage disease type iii
|
|
US12077501B2
(en)
|
2017-06-14 |
2024-09-03 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
US11786607B2
(en)
|
2017-06-15 |
2023-10-17 |
Modernatx, Inc. |
RNA formulations
|
|
WO2019006374A1
(en)
|
2017-06-30 |
2019-01-03 |
Duke University |
ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULI-SENSITIVE BIOPOLYMER NETWORKS
|
|
RU2020103379A
(ru)
|
2017-07-04 |
2021-08-04 |
Куревак Аг |
Новые молекулы нуклеиновых кислот
|
|
BR112020002627A2
(pt)
|
2017-08-10 |
2020-07-28 |
Yisheng Biopharma (Singapore) Pte Ltd |
composição, uso de pic, pelo menos um composto antibiótico ou poliamida, pelo menos um íon positivo e hbsag, e, composição estável para tratamento e/ou prevenção de infecção pelo vírus da hepatite b
|
|
CA3073020A1
(en)
|
2017-08-16 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
US11524932B2
(en)
|
2017-08-17 |
2022-12-13 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
CN111246854A
(zh)
|
2017-08-17 |
2020-06-05 |
宾夕法尼亚大学理事会 |
编码单纯疱疹病毒糖蛋白的修饰mrna疫苗及其用途
|
|
EP3668834B1
(en)
*
|
2017-08-17 |
2024-10-02 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
WO2019036028A1
(en)
|
2017-08-17 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS
|
|
MA50751A
(fr)
*
|
2017-08-18 |
2020-06-24 |
Modernatx Inc |
Vaccins à base d'arnm efficaces
|
|
US11602557B2
(en)
|
2017-08-22 |
2023-03-14 |
Cure Vac SE |
Bunyavirales vaccine
|
|
WO2019046809A1
(en)
|
2017-08-31 |
2019-03-07 |
Modernatx, Inc. |
METHODS OF MANUFACTURING LIPID NANOPARTICLES
|
|
EP3681514A4
(en)
|
2017-09-14 |
2021-07-14 |
ModernaTX, Inc. |
RNA VACZINE AGAINST ZIKA VIRUS
|
|
EP3707271A1
(en)
|
2017-11-08 |
2020-09-16 |
CureVac AG |
Rna sequence adaptation
|
|
EP3723796A1
(en)
|
2017-12-13 |
2020-10-21 |
CureVac AG |
Flavivirus vaccine
|
|
EP3728634A1
(en)
|
2017-12-21 |
2020-10-28 |
CureVac AG |
Linear double stranded dna coupled to a single support or a tag and methods for producing said linear double stranded dna
|
|
US12296018B2
(en)
|
2018-01-26 |
2025-05-13 |
Duke University |
Albumin binding peptide-drug (AlBiPeD) conjugates and methods of making and using same
|
|
WO2019148101A1
(en)
|
2018-01-29 |
2019-08-01 |
Modernatx, Inc. |
Rsv rna vaccines
|
|
CA3091558A1
(en)
|
2018-04-17 |
2019-10-24 |
Curevac Ag |
Novel rsv rna molecules and compositions for vaccination
|
|
EP3788343B1
(en)
|
2018-04-30 |
2024-03-27 |
Duke University |
Stimuli-responsive peg-like polymer-based drug delivery platform
|
|
CA3101454A1
(en)
*
|
2018-05-30 |
2019-12-05 |
Translate Bio, Inc. |
Messenger rna vaccines and uses thereof
|
|
CA3100276A1
(en)
|
2018-06-06 |
2019-12-12 |
Massachusetts Institute Of Technology |
Circular rna for translation in eukaryotic cells
|
|
PL3805198T3
(pl)
|
2018-06-08 |
2024-02-12 |
Fujifilm Corporation |
Związek, jego sól i cząstki lipidowe
|
|
US12357580B2
(en)
|
2018-06-19 |
2025-07-15 |
The Board Of Regents Of The University Of Texas System |
Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids
|
|
WO2020002525A1
(en)
|
2018-06-27 |
2020-01-02 |
Curevac Ag |
Novel lassa virus rna molecules and compositions for vaccination
|
|
SG11202012349QA
(en)
*
|
2018-06-27 |
2021-01-28 |
Medicago Inc |
Influenza virus hemagglutinin mutants
|
|
BR112020025601A8
(pt)
|
2018-06-28 |
2022-07-05 |
Tesla Automation GmbH |
Biorreator para a transcrição in vitro de rna
|
|
EP3829622A4
(en)
|
2018-08-02 |
2022-05-11 |
Duke University |
DOUBLE AGONIST FUSION PROTEINS
|
|
WO2020037102A1
(en)
*
|
2018-08-15 |
2020-02-20 |
University Of Florida Research Foundation, Inc. |
Methods of sensitizing tumors to treatment with immune checkpoint inhibitors
|
|
WO2020051220A1
(en)
*
|
2018-09-04 |
2020-03-12 |
The Board of the Regents of the University of Texas System |
Compositions and methods for organ specific delivery of nucleic acids
|
|
CN112996519B
(zh)
*
|
2018-09-04 |
2025-02-28 |
德克萨斯大学系统董事会 |
用于核酸的器官特异性递送的组合物和方法
|
|
WO2020051541A1
(en)
|
2018-09-07 |
2020-03-12 |
Duke University |
Nanoparticulate drug delivery systems
|
|
US20210369862A1
(en)
*
|
2018-09-18 |
2021-12-02 |
Universiteit Gent |
Therapeutic nanoparticles and methods of use thereof
|
|
US12263248B2
(en)
|
2018-09-19 |
2025-04-01 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
AU2019345067A1
(en)
|
2018-09-19 |
2021-04-08 |
Modernatx, Inc. |
High-purity peg lipids and uses thereof
|
|
MA53650A
(fr)
|
2018-09-19 |
2021-07-28 |
Modernatx Inc |
Lipides peg et leurs utilisations
|
|
CN113271926A
(zh)
|
2018-09-20 |
2021-08-17 |
摩登纳特斯有限公司 |
脂质纳米颗粒的制备及其施用方法
|
|
IL281615B2
(en)
|
2018-09-21 |
2026-01-01 |
Acuitas Therapeutics Inc |
Systems and methods for producing lipid nanoparticles and liposomes
|
|
US12419965B2
(en)
|
2018-10-01 |
2025-09-23 |
BioNTech SE |
RNA particles comprising polysarcosine
|
|
CN113166783B
(zh)
|
2018-10-09 |
2024-10-11 |
不列颠哥伦比亚大学 |
包含无有机溶剂和去污剂的转染活性囊泡的组合物和系统以及与之相关的方法
|
|
JP7543259B2
(ja)
*
|
2018-10-18 |
2024-09-02 |
アクイタス セラピューティクス インコーポレイテッド |
活性剤の脂質ナノ粒子送達のための脂質
|
|
KR20210081325A
(ko)
*
|
2018-10-19 |
2021-07-01 |
노우스콤 아게 |
경골어류 불변 사슬 암 백신
|
|
WO2020095812A1
(ja)
|
2018-11-08 |
2020-05-14 |
富士フイルム株式会社 |
積層圧電素子および電気音響変換器
|
|
KR102077772B1
(ko)
|
2018-11-29 |
2020-02-17 |
주식회사 바이오앱 |
광견병 예방용 백신 조성물 및 이의 제조 방법
|
|
JP7445657B2
(ja)
|
2018-12-06 |
2024-03-07 |
アークトゥラス・セラピューティクス・インコーポレイテッド |
オルニチントランスカルバミラーゼ欠損症を処置するための組成物および方法
|
|
TW202039534A
(zh)
|
2018-12-14 |
2020-11-01 |
美商美國禮來大藥廠 |
KRAS變體mRNA分子
|
|
US12492425B2
(en)
|
2018-12-21 |
2025-12-09 |
CureVac SE |
Methods for RNA analysis
|
|
CA3118034A1
(en)
|
2018-12-21 |
2020-06-25 |
Curevac Ag |
Rna for malaria vaccines
|
|
MY202837A
(en)
*
|
2019-01-11 |
2024-05-24 |
Acuitas Therapeutics Inc |
Lipids for lipid nanoparticle delivery of active agents
|
|
US20220133908A1
(en)
|
2019-02-08 |
2022-05-05 |
Curevac Ag |
Coding rna administered into the suprachoroidal space in the treatment of ophthalmic diseases
|
|
EP4729125A2
(en)
*
|
2019-02-21 |
2026-04-22 |
Centivax, Inc. |
Optimized vaccine compositions and methods for making the same
|
|
EP3938379A4
(en)
|
2019-03-15 |
2023-02-22 |
ModernaTX, Inc. |
Hiv rna vaccines
|
|
EP3956459A4
(en)
*
|
2019-04-15 |
2023-01-11 |
Precision Nanosystems Inc |
NONVIRAL MODIFICATION OF T LYMPHOCYTE GENE EXPRESSION
|
|
CN110124019B
(zh)
*
|
2019-04-22 |
2022-09-23 |
海南医学院 |
细菌化肿瘤细胞疫苗及其制备方法
|
|
EP3962521A1
(en)
|
2019-05-02 |
2022-03-09 |
University of Florida Research Foundation, Inc. |
Compositions for treatment of diffuse intrinsic pontine glioma
|
|
WO2020237227A1
(en)
*
|
2019-05-22 |
2020-11-26 |
Massachusetts Institute Of Technology |
Circular rna compositions and methods
|
|
WO2020246581A1
(ja)
|
2019-06-07 |
2020-12-10 |
富士フイルム株式会社 |
脂質組成物
|
|
AU2020290516B2
(en)
*
|
2019-06-14 |
2026-01-29 |
Dnalite Therapeutics, Inc. |
Compositions and methods for biological delivery vehicles
|
|
US20220313813A1
(en)
|
2019-06-18 |
2022-10-06 |
Curevac Ag |
Rotavirus mrna vaccine
|
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
|
US20230097090A1
(en)
*
|
2019-08-14 |
2023-03-30 |
Acuitas Therapeutics, Inc. |
Improved lipid nanoparticles for delivery of nucleic acids
|
|
EP4013880A1
(en)
|
2019-08-14 |
2022-06-22 |
CureVac AG |
Rna combinations and compositions with decreased immunostimulatory properties
|
|
AU2020350759A1
(en)
|
2019-09-19 |
2022-03-31 |
Modernatx, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
BR112022004936A2
(pt)
|
2019-09-19 |
2022-06-14 |
Modernatx Inc |
Compostos lipídicos contendo carbonato e composições para distribuição intracelular de agentes terapêuticos
|
|
CN114729376A
(zh)
|
2019-09-23 |
2022-07-08 |
欧米茄治疗公司 |
用于调节肝细胞核因子4α(HNF4α)基因表达的组合物和方法
|
|
AU2020355000A1
(en)
|
2019-09-23 |
2022-03-17 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating apolipoprotein B (APOB) gene expression
|
|
EP4059505B1
(en)
*
|
2019-11-15 |
2024-02-21 |
FUJIFILM Corporation |
Lipid composition
|
|
KR20220121246A
(ko)
|
2019-12-20 |
2022-08-31 |
큐어백 아게 |
핵산 전달용 신규한 지질 나노입자
|
|
MX2022009460A
(es)
|
2020-02-04 |
2022-12-16 |
Curevac Ag |
Vacuna contra el coronavirus.
|
|
US11241493B2
(en)
|
2020-02-04 |
2022-02-08 |
Curevac Ag |
Coronavirus vaccine
|
|
US12194089B2
(en)
|
2020-02-04 |
2025-01-14 |
CureVac SE |
Coronavirus vaccine
|
|
KR20230004447A
(ko)
*
|
2020-02-14 |
2023-01-06 |
이더알엔에이 이뮤노테라피스 엔브이 |
비강 내 mRNA 백신
|
|
US11642407B2
(en)
|
2020-02-28 |
2023-05-09 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
|
CN113151312B
(zh)
*
|
2020-03-02 |
2022-12-09 |
中国科学院微生物研究所 |
新型冠状病毒SARS-CoV-2 mRNA疫苗及其制备方法和应用
|
|
JP7832114B2
(ja)
|
2020-03-03 |
2026-03-17 |
アークトゥラス・セラピューティクス・インコーポレイテッド |
オルニチントランスカルバミラーゼ欠損症の治療のための組成物及び方法
|
|
WO2021183563A1
(en)
|
2020-03-09 |
2021-09-16 |
Arcturus Therapeutics, Inc. |
Coronavirus vaccine compositions and methods
|
|
CN116096886A
(zh)
|
2020-03-11 |
2023-05-09 |
欧米茄治疗公司 |
用于调节叉头框p3(foxp3)基因表达的组合物和方法
|
|
US12194157B2
(en)
|
2020-04-09 |
2025-01-14 |
Finncure Oy |
Carrier for targeted delivery to a host
|
|
JP7681617B2
(ja)
|
2020-04-09 |
2025-05-22 |
スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド |
脂質ナノ粒子組成物
|
|
EP4132478A1
(en)
|
2020-04-09 |
2023-02-15 |
Finncure Oy |
Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses
|
|
EP4132576A1
(en)
|
2020-04-09 |
2023-02-15 |
Suzhou Abogen Biosciences Co., Ltd. |
Nucleic acid vaccines for coronavirus
|
|
BR112022021208A8
(pt)
*
|
2020-04-22 |
2023-02-23 |
Medicago Inc |
Supraestrutura compreendendo hemaglutinina de influenza modificada com interação reduzida com ácido siálico
|
|
EP3901261A1
(en)
|
2020-04-22 |
2021-10-27 |
BioNTech RNA Pharmaceuticals GmbH |
Coronavirus vaccine
|
|
MX2022015132A
(es)
*
|
2020-05-29 |
2023-03-08 |
CureVac SE |
Vacunas combinadas a base de acidos nucleicos.
|
|
BR112022024932A2
(pt)
*
|
2020-06-19 |
2022-12-27 |
Intervet Int Bv |
Vacina contra vírus da influenza a suína compreendendo um constructo de ácido nucleico que possui uma ordem específica de genes
|
|
JP2023530132A
(ja)
*
|
2020-06-19 |
2023-07-13 |
インターベット インターナショナル ベー． フェー． |
２つの異なるｒｎａレプリコン粒子を含むブタインフルエンザａウイルスワクチン
|
|
WO2025056938A1
(en)
|
2023-09-11 |
2025-03-20 |
BioNTech SE |
Rna compositions for delivery of incretin agents
|
|
CA3187138A1
(en)
*
|
2020-06-26 |
2021-12-30 |
Carisma Therapeutics Inc. |
Mrna transfection of immune cells
|
|
KR20230034333A
(ko)
*
|
2020-07-02 |
2023-03-09 |
라이프 테크놀로지스 코포레이션 |
트리뉴클레오티드 캡 유사체, 제조 및 이의 용도
|
|
WO2022016070A1
(en)
|
2020-07-16 |
2022-01-20 |
Acuitas Therapeutics, Inc. |
Cationic lipids for use in lipid nanoparticles
|
|
MX2023000802A
(es)
*
|
2020-07-17 |
2023-02-27 |
Sanofi Pasteur |
Compuestos lipidicos escindibles, composiciones que los contienen y usos de los mismos.
|
|
WO2022023559A1
(en)
|
2020-07-31 |
2022-02-03 |
Curevac Ag |
Nucleic acid encoded antibody mixtures
|
|
CN114073762B
(zh)
*
|
2020-08-12 |
2023-07-21 |
中国人民解放军军事科学院军事医学研究院 |
一种含有Omp19和VirB8蛋白的布鲁氏菌病双组分疫苗
|
|
US12178921B2
(en)
|
2020-08-14 |
2024-12-31 |
Arcturus Therapeutics, Inc. |
Method of lyophilizing lipid nanoparticles
|
|
CN114073677B
(zh)
*
|
2020-08-20 |
2023-06-09 |
深圳深信生物科技有限公司 |
一种脂质纳米颗粒
|
|
US11406703B2
(en)
|
2020-08-25 |
2022-08-09 |
Modernatx, Inc. |
Human cytomegalovirus vaccine
|
|
CA3170743A1
(en)
|
2020-08-31 |
2022-03-03 |
Susanne RAUCH |
Multivalent nucleic acid based coronavirus vaccines
|
|
JP2023546175A
(ja)
|
2020-10-14 |
2023-11-01 |
ジョージ・メイソン・リサーチ・ファウンデーション・インコーポレイテッド |
脂質ナノ粒子製造の方法及びそれに由来する組成物
|
|
WO2022099003A1
(en)
*
|
2020-11-06 |
2022-05-12 |
Sanofi |
Lipid nanoparticles for delivering mrna vaccines
|
|
JP2023548587A
(ja)
*
|
2020-11-09 |
2023-11-17 |
トランスレイト バイオ， インコーポレイテッド |
コドン最適化したｍＲＮＡの送達のための改善された組成物
|
|
US20240041785A1
(en)
*
|
2020-11-16 |
2024-02-08 |
BioNTech SE |
Compositions and methods for stabilization of lipid nanoparticle mrna vaccines
|
|
AU2021379090A1
(en)
|
2020-11-16 |
2023-06-15 |
BioNTech SE |
Lnp compositions comprising rna and methods for preparing, storing and using the same
|
|
AR124065A1
(es)
*
|
2020-11-16 |
2023-02-08 |
BioNTech SE |
Composiciones de lnp que comprenden rna y métodos para preparar, almacenar y utilizar las mismas
|
|
WO2022218503A1
(en)
|
2021-04-12 |
2022-10-20 |
BioNTech SE |
Lnp compositions comprising rna and methods for preparing, storing and using the same
|
|
US20240033344A1
(en)
|
2020-11-16 |
2024-02-01 |
BioNTech SE |
Pharmaceutical compositions comprising particles and mrna and methods for preparing and storing the same
|
|
IL303195A
(en)
|
2020-11-25 |
2023-07-01 |
Akagera Medicines Inc |
Lipid nanoparticles for delivery of nucleic acids and related methods of use
|
|
WO2022110099A1
(en)
*
|
2020-11-30 |
2022-06-02 |
Guangzhou Argorna Biopharmaceuticals Co., Ltd. |
Coronavirus vaccines and uses thereof
|
|
CN112480217B
(zh)
*
|
2020-11-30 |
2022-04-08 |
广州阿格纳生物医药制造有限公司 |
基于SARS-CoV-2的S抗原蛋白的疫苗和组合物
|
|
US20240024466A1
(en)
*
|
2020-12-07 |
2024-01-25 |
Trustees Of Tufts College |
Lipidoid compositions and methods of use thereof
|
|
WO2022137133A1
(en)
|
2020-12-22 |
2022-06-30 |
Curevac Ag |
Rna vaccine against sars-cov-2 variants
|
|
WO2022135993A2
(en)
|
2020-12-22 |
2022-06-30 |
Curevac Ag |
Pharmaceutical composition comprising lipid-based carriers encapsulating rna for multidose administration
|
|
US20240156946A1
(en)
|
2020-12-22 |
2024-05-16 |
CureVac SE |
Rna vaccine against sars-cov-2 variants
|
|
CN112741078B
(zh)
*
|
2020-12-24 |
2022-03-25 |
山东省海洋科学研究院(青岛国家海洋科学研究中心) |
一种大泷六线鱼精子生产性冷冻保存方法
|
|
US12329811B2
(en)
|
2021-01-11 |
2025-06-17 |
Modernatx, Inc. |
Seasonal RNA influenza virus vaccines
|
|
WO2022155195A1
(en)
*
|
2021-01-12 |
2022-07-21 |
Peranteau William |
Ionizable lipid nanoparticles for in utero mrna delivery
|
|
WO2022155421A1
(en)
*
|
2021-01-15 |
2022-07-21 |
University Of Rochester |
Staphylococcus aureus antigen-based nucleic acid vaccines
|
|
WO2022162027A2
(en)
|
2021-01-27 |
2022-08-04 |
Curevac Ag |
Method of reducing the immunostimulatory properties of in vitro transcribed rna
|
|
CN113144186B
(zh)
*
|
2021-02-09 |
2023-09-29 |
中国医学科学院医学生物学研究所 |
一种水痘-带状疱疹疫苗组合物及其制备方法和应用
|
|
US20240100145A1
(en)
*
|
2021-03-05 |
2024-03-28 |
Moderna TX, Inc. |
Vlp enteroviral vaccines
|
|
KR102778906B1
(ko)
*
|
2021-03-08 |
2025-03-12 |
아이진 주식회사 |
SARS-CoV-2 예방 백신 조성물
|
|
EP4313938A1
(en)
*
|
2021-03-24 |
2024-02-07 |
Modernatx, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
US20240181037A1
(en)
|
2021-03-26 |
2024-06-06 |
Glaxosmithkline Biologicals Sa |
Immunogenic compositions
|
|
EP4312988A2
(en)
|
2021-03-31 |
2024-02-07 |
CureVac SE |
Syringes containing pharmaceutical compositions comprising rna
|
|
CN115197080A
(zh)
*
|
2021-04-08 |
2022-10-18 |
厦门赛诺邦格生物科技股份有限公司 |
一种聚乙二醇化脂质及其修饰的脂质体、含该脂质体的药物组合物及其制剂和应用
|
|
WO2022215036A1
(en)
|
2021-04-08 |
2022-10-13 |
Vaxthera Sas |
Coronavirus vaccine comprising a mosaic protein
|
|
AU2022256732A1
(en)
|
2021-04-12 |
2023-10-19 |
Biontech Delivery Technologies Gmbh |
Rna compositions comprising a buffer substance and methods for preparing, storing and using the same
|
|
WO2022221335A1
(en)
*
|
2021-04-13 |
2022-10-20 |
Modernatx, Inc. |
Respiratory virus combination vaccines
|
|
WO2022225368A1
(ko)
|
2021-04-22 |
2022-10-27 |
(주)인벤티지랩 |
지질 나노입자의 제조 방법 및 이의 제조 장치
|
|
KR102856912B1
(ko)
|
2021-04-22 |
2025-09-08 |
(주)인벤티지랩 |
지질 나노입자의 제조 방법 및 이의 제조 장치
|
|
WO2022232684A1
(en)
*
|
2021-04-30 |
2022-11-03 |
Trustees Of Tufts College |
Lipidoid nanoparticles for the treatment of diseases and disorders
|
|
CA3171589A1
(en)
|
2021-05-03 |
2022-11-03 |
Moritz THRAN |
Improved nucleic acid sequence for cell type specific expression
|
|
CN113354742A
(zh)
*
|
2021-05-10 |
2021-09-07 |
重庆市畜牧科学院 |
一种布鲁氏杆菌基因工程亚单位疫苗及其制备方法和应用
|
|
KR20240009952A
(ko)
|
2021-05-19 |
2024-01-23 |
다이이찌 산쿄 가부시키가이샤 |
인플루엔자 바이러스 핵산 지질 입자 백신
|
|
WO2022245888A1
(en)
*
|
2021-05-19 |
2022-11-24 |
Modernatx, Inc. |
Seasonal flu rna vaccines and methods of use
|
|
KR20240022610A
(ko)
*
|
2021-06-18 |
2024-02-20 |
사노피 |
다가 인플루엔자 백신
|
|
EP4342929B1
(en)
*
|
2021-06-30 |
2026-02-04 |
Jenkem Technology Co. Ltd. (Tianjin) |
Polyethylene glycol lipid and use thereof
|
|
CN114149337B
(zh)
|
2021-07-07 |
2022-04-29 |
天津键凯科技有限公司 |
一种用于核酸递送的新型可电离脂质及其lnp组合物
|
|
EP4367242A2
(en)
|
2021-07-07 |
2024-05-15 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression
|
|
CN113264842B
(zh)
|
2021-07-21 |
2022-03-01 |
苏州科锐迈德生物医药科技有限公司 |
一种脂质化合物及包含其的脂质载体、核酸脂质纳米粒组合物和药物制剂
|
|
CN115403761B
(zh)
|
2021-07-23 |
2025-04-25 |
天津键凯科技有限公司 |
一种多元甘醇修饰的脂质化合物及其制备方法和应用
|
|
CA3171750A1
(en)
|
2021-07-30 |
2023-02-02 |
Tim SONNTAG |
Mrnas for treatment or prophylaxis of liver diseases
|
|
CN113577258B
(zh)
*
|
2021-07-31 |
2024-04-16 |
山东兴瑞生物科技有限公司 |
一种双靶点mRNA疫苗及其制备方法
|
|
WO2023023589A2
(en)
*
|
2021-08-18 |
2023-02-23 |
The Trustees Of The University Of Pennsylvania |
Mrna vaccines against tick salivary proteins, and methods of using same
|
|
JP2024534915A
(ja)
|
2021-09-03 |
2024-09-26 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
自己増幅性メッセンジャーリボ核酸におけるヌクレオチド塩基の置換
|
|
WO2023031392A2
(en)
|
2021-09-03 |
2023-03-09 |
CureVac SE |
Novel lipid nanoparticles for delivery of nucleic acids comprising phosphatidylserine
|
|
MX2024002726A
(es)
|
2021-09-03 |
2024-03-20 |
CureVac SE |
Nuevas nanoparticulas lipidicas para la administracion de acidos nucleicos.
|
|
KR20240096468A
(ko)
*
|
2021-09-22 |
2024-06-26 |
에이치디티 바이오 코포레이션 |
감염병에 대한 rna 백신
|
|
WO2023053017A2
(en)
*
|
2021-09-28 |
2023-04-06 |
Seqirus Inc. |
Ionizable cationic compounds for messenger rna delivery
|
|
WO2023057596A1
(en)
*
|
2021-10-06 |
2023-04-13 |
Leon-Nanodrugs Gmbh |
Method for preparing lipid nanoparticles
|
|
WO2023056912A1
(en)
*
|
2021-10-08 |
2023-04-13 |
Suzhou Abogen Biosciences Co., Ltd. |
Nucleic acid vaccines for vzv
|
|
WO2023061460A1
(zh)
*
|
2021-10-15 |
2023-04-20 |
厦门赛诺邦格生物科技股份有限公司 |
含氮的阳离子脂质及其应用
|
|
KR20240090727A
(ko)
|
2021-10-22 |
2024-06-21 |
세일 바이오메디슨스, 인크. |
Mrna 백신 조성물
|
|
WO2023073228A1
(en)
|
2021-10-29 |
2023-05-04 |
CureVac SE |
Improved circular rna for expressing therapeutic proteins
|
|
KR20230061895A
(ko)
*
|
2021-10-29 |
2023-05-09 |
주식회사 아이큐어비앤피 |
지질 나노입자 및 세포 투과성을 갖는 신규 펩타이드의 복합체
|
|
WO2023077170A1
(en)
*
|
2021-11-01 |
2023-05-04 |
Modernatx, Inc. |
Polynucleotides encoding integrin beta-6 and methods of use thereof
|
|
AU2022381813A1
(en)
*
|
2021-11-05 |
2024-06-20 |
Sanofi Pasteur Inc. |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
|
CN118488834A
(zh)
|
2021-11-23 |
2024-08-13 |
赛欧生物医药股份有限公司 |
细菌源性脂质组合物和其用途
|
|
JP2024543272A
(ja)
*
|
2021-11-29 |
2024-11-20 |
ザ ガバニング カウンシル オブ ザ ユニバーシティ オブ トロント |
マルチモチーフデンドロン及びその超分子構造ならびにその使用
|
|
US12186387B2
(en)
|
2021-11-29 |
2025-01-07 |
BioNTech SE |
Coronavirus vaccine
|
|
CN114099546A
(zh)
*
|
2021-12-06 |
2022-03-01 |
武汉汉密顿生物科技股份有限公司 |
一种基因修饰的人脐带间充质干细胞制剂在制备治疗糖尿病肾病药物中的应用
|
|
CA3242402A1
(en)
|
2021-12-16 |
2023-06-22 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
WO2023122080A1
(en)
|
2021-12-20 |
2023-06-29 |
Senda Biosciences, Inc. |
Compositions comprising mrna and lipid reconstructed plant messenger packs
|
|
CN114196556B
(zh)
*
|
2021-12-31 |
2023-08-01 |
重庆大学 |
一种高毒力蝗绿僵菌菌株及其构建方法
|
|
CN114957027B
(zh)
*
|
2022-01-13 |
2023-05-19 |
北京悦康科创医药科技股份有限公司 |
一种阳离子脂质化合物、包含其的组合物及用途
|
|
EP4467135A4
(en)
*
|
2022-01-17 |
2026-01-21 |
St Pharm Co Ltd |
IONIZABLE LIPID CONTAINING A BIODEGRADABLE ESTER BOND AND LIPID NANOPARTICLES COMPRISING IT
|
|
TW202330457A
(zh)
*
|
2022-01-19 |
2023-08-01 |
大陸商蘇州艾博生物科技有限公司 |
脂質化合物和脂質奈米顆粒組合物
|
|
WO2023144193A1
(en)
|
2022-01-25 |
2023-08-03 |
CureVac SE |
Mrnas for treatment of hereditary tyrosinemia type i
|
|
CA3242744A1
(en)
|
2022-01-27 |
2023-08-03 |
The Trustees Of The University Of Pennsylvania |
Pharmaceutical compositions for the administration of herpes simplex virus antigens and associated methods
|
|
WO2023146356A1
(ko)
|
2022-01-28 |
2023-08-03 |
성균관대학교산학협력단 |
막구조화 단백질이 결합된 항체를 포함하는 항체 결합 지질나노입자
|
|
US20250099614A1
(en)
|
2022-01-28 |
2025-03-27 |
CureVac SE |
Nucleic acid encoded transcription factor inhibitors
|
|
WO2023143600A1
(zh)
*
|
2022-01-30 |
2023-08-03 |
康希诺生物股份公司 |
一种用于核酸递送的新型可电离脂质及其lnp组合物和疫苗
|
|
CN116554042A
(zh)
*
|
2022-01-30 |
2023-08-08 |
康希诺生物股份公司 |
一种用于核酸递送的新型可电离脂质及其lnp组合物和疫苗
|
|
WO2023148303A1
(de)
|
2022-02-02 |
2023-08-10 |
Mslsolutions Gmbh |
Verfahren zur medikament- und impfstoffherstellung
|
|
DE102022115653A1
(de)
|
2022-02-02 |
2023-08-03 |
Mslsolutions Gmbh |
Verfahren zur Medikament- und Impfstoffherstellung
|
|
WO2023151570A1
(en)
*
|
2022-02-09 |
2023-08-17 |
Suzhou Abogen Biosciences Co., Ltd. |
Nucleic acid vaccines for rabies
|
|
WO2023154451A1
(en)
|
2022-02-10 |
2023-08-17 |
Christiana Care Gene Editing Institute, Inc. |
Methods for lipid nanoparticle delivery of crispr/cas system
|
|
CN114921481B
(zh)
*
|
2022-02-25 |
2024-01-30 |
上海赛伦生物技术股份有限公司 |
一种狂犬病病毒修饰性mRNA疫苗及其制备方法
|
|
WO2023165681A1
(en)
|
2022-03-01 |
2023-09-07 |
BioNTech SE |
Rna lipid nanoparticles (lnps) comprising a polyoxazoline and/or polyoxazine polymer
|
|
US20250127882A1
(en)
*
|
2022-03-11 |
2025-04-24 |
Chiou-Hwa YUH |
Nucleic acid-lipid nanoparticle and method using the same
|
|
CN114848808B
(zh)
*
|
2022-03-24 |
2023-04-25 |
四川大学 |
基于阳离子脂多肽及细胞因子的免疫增强剂及制法、应用
|
|
WO2023193892A1
(en)
|
2022-04-05 |
2023-10-12 |
BioNTech SE |
Nucleic acid compositions comprising an inorganic polyphosphate and methods for preparing, storing and using the same
|
|
WO2023196914A1
(en)
*
|
2022-04-08 |
2023-10-12 |
Modernatx, Inc. |
Influenza nucleic acid compositions and uses thereof
|
|
IL316048A
(en)
|
2022-04-13 |
2024-11-01 |
Caribou Biosciences Inc |
Therapeutic applications of V-type CRISPR systems
|
|
WO2023201432A1
(en)
*
|
2022-04-20 |
2023-10-26 |
Sunshine Biopharma Inc. |
Composition for the inhibition of nrf2 and uses thereof in cancer therapy
|
|
EP4531819A2
(en)
|
2022-05-25 |
2025-04-09 |
Akagera Medicines, Inc. |
Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
|
|
KR20250021330A
(ko)
|
2022-05-25 |
2025-02-12 |
비온테크 에스이 |
원숭이두창 항원 전달을 위한 rna 조성물 및 관련 방법
|
|
WO2023227608A1
(en)
|
2022-05-25 |
2023-11-30 |
Glaxosmithkline Biologicals Sa |
Nucleic acid based vaccine encoding an escherichia coli fimh antigenic polypeptide
|
|
WO2023242817A2
(en)
|
2022-06-18 |
2023-12-21 |
Glaxosmithkline Biologicals Sa |
Recombinant rna molecules comprising untranslated regions or segments encoding spike protein from the omicron strain of severe acute respiratory coronavirus-2
|
|
KR20250068590A
(ko)
*
|
2022-06-22 |
2025-05-16 |
플래그쉽 파이어니어링 이노베이션스 브이, 인크. |
Myc 발현을 조절하기 위한 제형
|
|
CN114989182B
(zh)
*
|
2022-06-23 |
2023-06-23 |
尧唐(上海)生物科技有限公司 |
脂质化合物、包含其的组合物及应用
|
|
WO2024002985A1
(en)
|
2022-06-26 |
2024-01-04 |
BioNTech SE |
Coronavirus vaccine
|
|
EP4551247A1
(en)
|
2022-07-07 |
2025-05-14 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Immunogens and methods for inducing an immune response
|
|
CN115094573B
(zh)
*
|
2022-07-18 |
2024-03-22 |
南通大学 |
一种抗菌纳米敷料及其制备方法
|
|
AU2023310896A1
(en)
|
2022-07-19 |
2025-01-30 |
Shenzhen Shenxin Biotechnology Co., Ltd. |
Mrna for sars-cov-2 s protein and use thereof
|
|
AU2023317702A1
(en)
|
2022-08-01 |
2025-01-09 |
BioNTech SE |
Nucleic acid compositions comprising amphiphilic oligo ethylene glycol (oeg)-conjugated compounds and methods of using such compounds and compositions
|
|
CN114989027B
(zh)
*
|
2022-08-03 |
2023-01-31 |
深圳市瑞吉生物科技有限公司 |
用于递送核酸的阳离子脂质化合物和组合物及用途
|
|
EP4565572A1
(en)
|
2022-08-05 |
2025-06-11 |
Life Technologies Corporation |
Lipids for nucleic acid delivery
|
|
CN115948345B
(zh)
*
|
2022-08-29 |
2025-03-11 |
上海海洋大学 |
草鱼CD3e杂交瘤细胞株及单克隆抗体和应用
|
|
CN116769786A
(zh)
*
|
2022-09-07 |
2023-09-19 |
贵州大学 |
飞蝗气味结合蛋白LmOBP11基因及其编码蛋白与应用
|
|
WO2024054882A1
(en)
*
|
2022-09-09 |
2024-03-14 |
Spark Therapeutics, Inc. |
Enhancing non-viral dna delivery and expression
|
|
WO2024063788A1
(en)
|
2022-09-23 |
2024-03-28 |
BioNTech SE |
Compositions for delivery of malaria antigens and related methods
|
|
EP4590331A1
(en)
|
2022-09-23 |
2025-07-30 |
BioNTech SE |
Compositions for delivery of plasmodium csp antigens and related methods
|
|
WO2024063789A1
(en)
|
2022-09-23 |
2024-03-28 |
BioNTech SE |
Compositions for delivery of malaria antigens and related methods
|
|
JP2025533541A
(ja)
|
2022-09-23 |
2025-10-07 |
ビオンテック・ソシエタス・エウロパエア |
肝病期抗原の送達のための組成物及び関連方法
|
|
CN119947747A
(zh)
|
2022-09-26 |
2025-05-06 |
葛兰素史克生物有限公司 |
流感病毒疫苗
|
|
CN117917398A
(zh)
*
|
2022-10-21 |
2024-04-23 |
华中师范大学 |
一种可离子化脂质化合物、核酸药物分子递送系统及应用
|
|
WO2024091037A1
(ko)
*
|
2022-10-27 |
2024-05-02 |
에스티팜 주식회사 |
폐를 표적장기로 하는 생분해성 지질나노입자 약물 전달 제형 및 이의 활용
|
|
WO2024089229A1
(en)
|
2022-10-28 |
2024-05-02 |
CureVac SE |
Improved formulations comprising lipid-based carriers encapsulating rna
|
|
WO2024089638A1
(en)
|
2022-10-28 |
2024-05-02 |
Glaxosmithkline Biologicals Sa |
Nucleic acid based vaccine
|
|
CN120091992A
(zh)
*
|
2022-11-08 |
2025-06-03 |
三养控股公司 |
阳离子脂质及其制备方法
|
|
EP4615424A1
(en)
|
2022-11-10 |
2025-09-17 |
Sail Biomedicines, Inc. |
Rna compositions comprising lipid nanoparticles or lipid reconstructed natural messenger packs
|
|
EP4620945A1
(en)
*
|
2022-11-16 |
2025-09-24 |
Samyang Holdings Corporation |
Cationic lipids and method for preparing same
|
|
WO2024119098A1
(en)
*
|
2022-12-02 |
2024-06-06 |
Prime Medicine, Inc. |
Lipid nanoparticle (lnp) delivery systems and formulations
|
|
CN120435560A
(zh)
|
2022-12-16 |
2025-08-05 |
深圳深信生物科技有限公司 |
提高rna分子翻译效率和/或稳定性的utr及其应用
|
|
WO2024133160A1
(en)
|
2022-12-19 |
2024-06-27 |
Glaxosmithkline Biologicals Sa |
Hepatitis b compositions
|
|
JP2025542216A
(ja)
*
|
2022-12-20 |
2025-12-25 |
セキラス インコーポレイテッド |
脂質ナノ粒子組成物
|
|
CN120359207A
(zh)
*
|
2022-12-21 |
2025-07-22 |
南京吉迈生物技术有限公司 |
一种阳离子脂质材料的制备及应用
|
|
IL321425A
(en)
|
2022-12-23 |
2025-08-01 |
Biontech Delivery Tech Gmbh |
compound
|
|
CN115677518B
(zh)
*
|
2023-01-05 |
2023-04-14 |
北京悦康科创医药科技股份有限公司 |
用于递送核酸的可电离阳离子脂质化合物和组合物及用途
|
|
CN116042657A
(zh)
*
|
2023-01-16 |
2023-05-02 |
上海复诺健生物科技有限公司 |
自复制信使核糖核酸疫苗
|
|
JP2026503550A
(ja)
*
|
2023-01-20 |
2026-01-29 |
ポセイダ セラピューティクス，インコーポレイティド |
リピドイド化合物ならびに関連する組成物および使用
|
|
EP4654996A1
(en)
|
2023-01-27 |
2025-12-03 |
BioNTech SE |
Pharmaceutical compositions for delivery of herpes simplex virus glycoprotein c, glycoprotein d, and glycoprotein e antigens and related methods
|
|
CN121057577A
(zh)
|
2023-01-27 |
2025-12-02 |
赛欧生物医药股份有限公司 |
经修饰的脂质组合物及其用途
|
|
WO2024160936A1
(en)
|
2023-02-03 |
2024-08-08 |
Glaxosmithkline Biologicals Sa |
Rna formulation
|
|
WO2024167855A1
(en)
*
|
2023-02-06 |
2024-08-15 |
Emergent Product Development Gaithersburg Inc. |
Influenza hemagglutinin constructs and compositions
|
|
GB202302092D0
(en)
|
2023-02-14 |
2023-03-29 |
Glaxosmithkline Biologicals Sa |
Analytical method
|
|
WO2024174011A1
(pt)
|
2023-02-24 |
2024-08-29 |
Rossi Bergmann Bartira |
Lipossoma, método de preparo de um lipossoma, composição intranasal compreendendo lipossoma, método de preparo de composição intranasal, kit e uso da composição
|
|
KR20250153298A
(ko)
|
2023-03-08 |
2025-10-24 |
큐어백 에스이 |
핵산 전달을 위한 신규의 지질 나노입자 제형
|
|
WO2024193827A1
(en)
|
2023-03-23 |
2024-09-26 |
BioNTech SE |
Stabilized nucleic acid compositions and methods for preparing, storing and using the same
|
|
WO2024218154A1
(en)
*
|
2023-04-18 |
2024-10-24 |
Charité - Universitätsmedizin Berlin |
Nucleic acid vaccine for activating nkg2c+ natural killer cells
|
|
EP4698150A1
(en)
|
2023-04-19 |
2026-02-25 |
Sail Biomedicines, Inc. |
Delivery of polynucleotides from lipid nanoparticles comprising rna and ionizable lipids
|
|
WO2024220712A2
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Vaccine compositions
|
|
WO2024220752A2
(en)
|
2023-04-19 |
2024-10-24 |
Sail Biomedicines, Inc. |
Rna therapeutic compositions
|
|
EP4701658A1
(en)
|
2023-04-27 |
2026-03-04 |
GlaxoSmithKline Biologicals S.A. |
Influenza virus vaccines
|
|
WO2024223724A1
(en)
*
|
2023-04-27 |
2024-10-31 |
Glaxosmithkline Biologicals Sa |
Influenza virus vaccines
|
|
WO2024228044A1
(en)
|
2023-05-03 |
2024-11-07 |
BioNTech SE |
Optimized csp variants and related methods
|
|
WO2024228150A1
(en)
|
2023-05-03 |
2024-11-07 |
BioNTech SE |
Optimized csp variants and related methods
|
|
US20240417370A1
(en)
*
|
2023-05-05 |
2024-12-19 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
WO2024230934A1
(en)
|
2023-05-11 |
2024-11-14 |
CureVac SE |
Therapeutic nucleic acid for the treatment of ophthalmic diseases
|
|
WO2024243438A2
(en)
|
2023-05-23 |
2024-11-28 |
Omega Therapeutics, Inc. |
Compositions and methods for reducing cxcl9, cxcl10, and cxcl11 gene expression
|
|
AU2024278682A1
(en)
|
2023-05-26 |
2025-11-27 |
CureVac SE |
Cancer antigens
|
|
EP4731655A1
(en)
|
2023-06-23 |
2026-04-29 |
CureVac SE |
Nucleic acid encoded antibodies
|
|
KR102898792B1
(ko)
|
2023-06-26 |
2025-12-19 |
주식회사 무진메디 |
이온화 가능한 펩타이드를 이용한 지질 나노입자 기반 약물 전달체 및 이의 제조방법
|
|
WO2025007140A2
(en)
|
2023-06-30 |
2025-01-02 |
Christiana Care Gene Editing Institute, Inc. |
Nras gene knockout for treatment of cancer
|
|
WO2025006385A1
(en)
|
2023-06-30 |
2025-01-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Novel malaria vaccine comprising ama1 and ron2 antigens
|
|
WO2025011529A2
(en)
|
2023-07-07 |
2025-01-16 |
Shanghai Circode Biomed Co., Ltd. |
Circular rna vaccines for seasonal flu and methods of uses
|
|
CN119285790A
(zh)
*
|
2023-07-10 |
2025-01-10 |
康希诺(上海)生物研发有限公司 |
一种用于预防猫疱疹病毒感染的疫苗及其制备方法和用途
|
|
CN121816193A
(zh)
|
2023-07-21 |
2026-04-07 |
生物技术欧洲股份公司 |
用于递送疟原虫抗原的组合物及相关方法
|
|
WO2025024324A1
(en)
|
2023-07-21 |
2025-01-30 |
BioNTech SE |
Compositions for delivery of plasmodium antigens and related methods
|
|
IL325898A
(en)
|
2023-07-24 |
2026-03-01 |
BioNTech SE |
Compositions for administering Plasmodium antigens and related methods
|
|
WO2025027060A1
(en)
|
2023-07-31 |
2025-02-06 |
CureVac SE |
Nucleic acid encoded runx3 transcription factor
|
|
WO2025030154A1
(en)
|
2023-08-03 |
2025-02-06 |
The Trustees Of The University Of Pennsylvania |
Pharmaceutical compositions for delivery of herpes simplex virus glycoprotein b antigens and related methods
|
|
CN121772938A
(zh)
|
2023-08-03 |
2026-03-31 |
百欧恩泰欧洲股份公司 |
用于递送单纯疱疹病毒抗原的药物组合物及相关方法
|
|
WO2025036992A1
(en)
|
2023-08-16 |
2025-02-20 |
CureVac SE |
Rna conjugates
|
|
CN116785424B
(zh)
*
|
2023-08-17 |
2023-11-03 |
山东兴瑞生物科技有限公司 |
一种mRNA多价流感疫苗及其制备方法
|
|
CN121752588A
(zh)
|
2023-08-29 |
2026-03-27 |
上海环码生物医药有限公司 |
编码vegf多肽的环状rna、制剂和使用方法
|
|
WO2025054556A1
(en)
|
2023-09-07 |
2025-03-13 |
BioNTech SE |
Rna compositions for delivery of mpox antigens and related methods
|
|
WO2025054382A1
(en)
*
|
2023-09-07 |
2025-03-13 |
Board Of Regents, The University Of Texas System |
Coccidioides antigens and methods of their use
|
|
CN121844046A
(zh)
|
2023-09-11 |
2026-04-10 |
C·米库尔卡 |
用于递送肠促胰岛素剂的rna组合物
|
|
CN119591513A
(zh)
*
|
2023-09-11 |
2025-03-11 |
苏州星核迪赛生物技术有限公司 |
局部递送药物的材料及其应用
|
|
CN119330848B
(zh)
*
|
2023-10-19 |
2025-07-08 |
仁景(苏州)生物科技有限公司 |
用于递送的脂质化合物及脂质纳米颗粒
|
|
WO2025084582A1
(ko)
*
|
2023-10-19 |
2025-04-24 |
주식회사 삼양홀딩스 |
양이온성 지질 및 이의 제조방법
|
|
WO2025089792A1
(ko)
*
|
2023-10-24 |
2025-05-01 |
주식회사 삼양홀딩스 |
약물전달용 나노입자의 조성물
|
|
WO2025088088A1
(en)
|
2023-10-27 |
2025-05-01 |
CureVac SE |
Rna composition for improving cell therapy
|
|
WO2025092866A1
(zh)
*
|
2023-10-31 |
2025-05-08 |
仁景(苏州)生物科技有限公司 |
一种多价流感mRNA疫苗
|
|
KR20250064439A
(ko)
*
|
2023-11-02 |
2025-05-09 |
주식회사 삼양홀딩스 |
양이온성 지질 및 이의 제조방법
|
|
WO2025103803A1
(en)
|
2023-11-13 |
2025-05-22 |
CureVac SE |
Immunotherapy against neuronal and brain tumors
|
|
WO2025106930A1
(en)
|
2023-11-17 |
2025-05-22 |
Sail Biomedicines, Inc. |
Circular polyribonucleotides encoding glucagon-like peptide 2 (glp-2) and uses thereof
|
|
WO2025106915A1
(en)
|
2023-11-17 |
2025-05-22 |
Sail Biomedicines, Inc. |
Circular polyribonucleotides encoding glucagon-like peptide 1 (glp-1) and uses thereof
|
|
CN118307633B
(zh)
*
|
2023-11-24 |
2025-02-18 |
中国水产科学研究院黄海水产研究所 |
南极磷虾ace抑制肽lggif、ylggal、lgglnq及其应用
|
|
WO2025126071A1
(en)
|
2023-12-14 |
2025-06-19 |
Pfizer Inc. |
Rna molecules
|
|
WO2025132839A1
(en)
|
2023-12-21 |
2025-06-26 |
Glaxosmithkline Biologicals Sa |
Influenza virus vaccines
|
|
WO2025144938A1
(en)
|
2023-12-26 |
2025-07-03 |
Emmune, Inc. |
Systems for nucleic acid transfer
|
|
WO2025144907A1
(en)
*
|
2023-12-27 |
2025-07-03 |
Flagship Pioneering Innovations V, Inc. |
Kinase inhibitors and particles comprising myc modulators
|
|
KR20250104719A
(ko)
*
|
2023-12-29 |
2025-07-08 |
주식회사 삼양홀딩스 |
약물전달용 나노입자의 조성물
|
|
CN117511969B
(zh)
*
|
2024-01-04 |
2024-03-19 |
华南农业大学 |
一种mRNA、制备方法、用途和疫苗
|
|
WO2025166323A2
(en)
|
2024-02-02 |
2025-08-07 |
Editas Medicine, Inc. |
Crispr-related methods and compositions targeting lipoprotein (a) expression
|
|
WO2025186725A2
(en)
|
2024-03-06 |
2025-09-12 |
Pfizer Inc. |
Improved lnp formulations and uses thereof
|
|
WO2025189068A1
(en)
*
|
2024-03-08 |
2025-09-12 |
The Trustees Of The University Of Pennsylvania |
Mrna-lipid nanoparticle immune modulators against allergic and inflammatory diseases
|
|
WO2025202937A1
(en)
|
2024-03-26 |
2025-10-02 |
BioNTech SE |
Cancer vaccines
|
|
WO2025201659A1
(en)
*
|
2024-03-28 |
2025-10-02 |
BioNTech SE |
Combination therapy comprising therapeutic rna cancer vaccines and anti-ctla4 antibodies for cancer treatment
|
|
GB202404607D0
(en)
|
2024-03-29 |
2024-05-15 |
Glaxosmithkline Biologicals Sa |
RNA formulation
|
|
US20250319206A1
(en)
|
2024-04-04 |
2025-10-16 |
Christina Care Gene Editing Institute, Inc. |
Crispr/cas gene editing of neh4 and/or neh5 domains in nrf2
|
|
WO2025213138A1
(en)
|
2024-04-05 |
2025-10-09 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma
|
|
WO2025213131A1
(en)
|
2024-04-05 |
2025-10-09 |
BioNTech SE |
Rna compositions for delivery of orthopox antigens and related methods
|
|
CN118085043B
(zh)
*
|
2024-04-17 |
2024-07-19 |
成都康华生物制品股份有限公司 |
结核分枝杆菌多免疫原抗原、编码其的多核苷酸、应用
|
|
WO2025226816A1
(en)
|
2024-04-23 |
2025-10-30 |
Christiana Care Gene Editing Institute, Inc. |
Methods of identifying and correlating crispr-induced exon skipping to phenotypic outcomes
|
|
CN118221797B
(zh)
*
|
2024-04-28 |
2025-02-18 |
内蒙古工业大学 |
一种具有脱敏效果的乳球蛋白肽及其应用
|
|
WO2025231114A1
(en)
|
2024-05-01 |
2025-11-06 |
Acuitas Therapeutics, Inc. |
Method of using lipid nanoparticles for intramuscular delivery
|
|
WO2025229572A1
(en)
|
2024-05-01 |
2025-11-06 |
Glaxosmithkline Biologicals Sa |
Epstein-barr virus antigen-encoding messenger ribonucleic acid and antigen protein vaccines
|
|
WO2025240356A1
(en)
*
|
2024-05-14 |
2025-11-20 |
Recode Therapeutics, Inc. |
Lipid nanoparticles for hepatic delivery
|
|
WO2025240833A1
(en)
|
2024-05-17 |
2025-11-20 |
Acuitas Therapeutics, Inc. |
Galnac lipid compounds for use in lipid nanoparticles
|
|
WO2025242815A1
(en)
|
2024-05-23 |
2025-11-27 |
CureVac SE |
Immunotherapy of squamous cell carcinoma
|
|
CN118370275B
(zh)
*
|
2024-06-21 |
2024-09-06 |
中国科学院昆明动物研究所 |
一种产生母源性半克隆小鼠的方法
|
|
CN118374514A
(zh)
*
|
2024-06-26 |
2024-07-23 |
成都康华生物制品股份有限公司 |
一种带状疱疹mRNA及应用
|
|
WO2026003582A2
(en)
|
2024-06-27 |
2026-01-02 |
Axelyf ehf. |
Lipids and lipid nanoparticles
|
|
WO2026010842A1
(en)
*
|
2024-07-01 |
2026-01-08 |
The Trustees Of The University Of Pennsylvania |
Use of lipid nanoparticle mrna for tert specific cancer immunotherapy
|
|
WO2026008743A1
(en)
|
2024-07-02 |
2026-01-08 |
Sanofi Pasteur Inc. |
Water-soluble polyanionic polymer as adjuvant for carrier-formulated nucleic acid
|
|
WO2026015882A1
(en)
|
2024-07-12 |
2026-01-15 |
BioNTech SE |
Hsv antigen fragments and related methods
|
|
WO2026018181A1
(en)
|
2024-07-17 |
2026-01-22 |
Pfizer Inc. |
Immunogenic compositions and uses thereof
|
|
WO2026018213A1
(en)
|
2024-07-18 |
2026-01-22 |
Vaxthera Sas |
A broadly protective mosaic vaccine against highly pathogenic avian influenza viruses
|
|
WO2026049650A1
(ru)
*
|
2024-08-28 |
2026-03-05 |
Федеральное государственное бюджетное учреждение науки Институт физической химии и электрохимии им. А.Н. Фрумкина Российской академии наук |
Поверхностно-активное вещество, содержащее разветвленные гидрофобные цепи с остатками аминокислот в точке ветвления
|
|
CN120041511B
(zh)
*
|
2025-04-24 |
2025-09-02 |
浙江大学 |
IL-4受体激活剂或M-CSF受体激活剂在增强mRNA编辑巨噬细胞效率中的应用
|
|
CN121108277B
(zh)
*
|
2025-11-13 |
2026-04-03 |
青岛农业大学 |
一种石斑鱼肠孢虫孢壁蛋白swp26及其多克隆抗体的制备与应用
|